This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Victor A. Levin, MD; Herschel S. Zackheim, MD; Jane Liu
San Francisco

Arch Dermatol. 1982;118(7):450-451.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Applied topically, carmustine (a nitrosourea compound) is an effective treatment of the cutaneous lymphoma, mycosis fungoides.¹ Because this therapy is usually a long-term, outpatient treatment procedure, the possibility that pharmacist or patient mishandling might affect the stability of carmustine, a compound that is intrinsically unstable because of the "N-nitroso" moiety, has caused concern among dermatologists.² In older protocols, patients were given bulk powder and instructions for making up the solutions at home. This procedure has obvious shortcomings; it would be preferable if the pharmacist could make up the alcohol solution of carmustine. This study was conducted to evaluate the stability of carmustine for the period that might pass between pharmacist preparation and patient use.

For total-body application, carmustine is dissolved in alcohol (usually 95% ethanol) and diluted with tap water to obtain a final concentration of approximately 10 mg/60 mL of a 10% alcohol solution. . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?